$14.16 +0.24 (%) Durata Therapeutics Inc. - NASDAQ

Sep. 18, 2014 | 04:00 PM

Partner Headlines

  1. Benzinga's Volume Movers

    Benzinga | Aug. 4, 2014 | 10:26AM EST
  2. Morning Market Movers

    Benzinga | Aug. 4, 2014 | 09:41AM EST
  3. Durata Therapeutics Announces US Launch of Dalvance

    Benzinga | Jul. 18, 2014 | 08:05AM EST
  4. Durata Therapeutics Initiates Enrollment in a Phase 3b Study of Dalvance in 1500 mg Single Dose

    Benzinga | Apr. 24, 2014 | 08:32AM EST
  5. Benzinga's Volume Movers

    Benzinga | Apr. 1, 2014 | 10:36AM EST
  6. Morning Market Movers

    Benzinga | Apr. 1, 2014 | 09:43AM EST
  7. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 1, 2014 | 08:13AM EST
  8. Benzinga's Top Initiations

    Benzinga | Mar. 18, 2014 | 08:04AM EST
  9. Benzinga's Top Initiations

    Benzinga | Mar. 6, 2014 | 08:35AM EST
  10. UPDATE: Wedbush Downgrades Durata Therapeutics as CBST/Hospira Litigation Overhang Looms

    Benzinga | Dec. 2, 2013 | 10:20AM EST
  11. Morning Market Losers

    Benzinga | Dec. 2, 2013 | 09:59AM EST
  12. UPDATE: Janney Capital Markets Initiates Coverage on Durata Therapeutics on Fundamentally Changing Antibiotic Treatment

    Benzinga | Nov. 13, 2013 | 08:38AM EST
  13. Durata Data on Dalbavancin Shows Primary Endpoints Met

    Benzinga | Oct. 2, 2013 | 07:33AM EST
  14. Durata Says EMA Review in Phase 3 Trial of Dalbavancin Met Primary Endpoints

    Benzinga | Jan. 4, 2013 | 01:35AM EST
  15. Durata Shares Lower as Co. Offers Phase 3 Clinical Trial Results for Dalbavancin in Treatment of ABSSSI

    Benzinga | Dec. 11, 2012 | 03:16AM EST
  16. FDA Designates Durata's Dalbavancin a Qualified Infectious Disease Product

    Benzinga | Nov. 5, 2012 | 00:54AM EST
  17. Durata Therapeutics Achieves Target Enrollment In Phase III

    Benzinga | Sep. 6, 2012 | 01:47AM EST
  18. DURATA THERAPT (DRTX) CEO Paul R Edick buys 5,000 Shares

    GuruFocus | Aug. 16, 2012 | 12:21PM EST
  19. Benzinga's Top Initiations

    Benzinga | Aug. 13, 2012 | 01:50AM EST
  20. UPDATE: Bank of America Initiates Durata Therapeutics at Buy with $12 PO

    Benzinga | Aug. 13, 2012 | 01:17AM EST
  21. Health Care Sector Wrap

    FoxBusiness | Aug. 9, 2012 | 10:40AM EST
  22. TreeHouse Foods, Alexco Resource Among Stocks hitting 52-Week Lows Thursday

    FoxBusiness | Aug. 9, 2012 | 06:32AM EST
  23. Health Care Sector Wrap

    FoxBusiness | Aug. 7, 2012 | 10:45AM EST
Trading Center